As such, the KPCLOH model enables the isolation of p53-deficient cells at distinct stages of transformation (Extended Data Fig. 2i,j), including an initial, intermediate evolutionary phase that connects p53 inactivation to the acquisition of cancer-initiating potential. Here, TP53 is linked to cancer.